Showing results (91-100 of 179) with videos related to
Sort By:
Pageof 18
Cancer Investigation|January 12, 2005
Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology GroupCorey J Langer, Yi Li, Timothy Jennings, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinomaS G Urba, A A Forastiere, G T Wolf, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2014
Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trialsA Argiris, S Li, M Ghebremichael, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neckA A Forastiere, R B Natale, B J Takasugi, et al.Cancer Research|July 1, 1988
Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patientsA A Forastiere, J F Belliveau, M P Goren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trialAthanassios Argiris, Musie Ghebremichael, Jill Gilbert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393A A Forastiere, T Leong, E Rowinsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagusA A Forastiere, M B Orringer, C Perez-Tamayo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology GroupMichael K Gibson, Yi Li, Barbara Murphy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinomaP G Corn, E I Heath, R Heitmiller, et al.Pageof 18